Clinical trial
Redefining BMI: The Body, Mind, and Inflammation Trial
Recruiting now · Not applicable · 1 countries · Registry ID NCT06532747
What this study is about
Emerging adulthood (18-25 years of age) is a critical developmental window to promote weight management and cardiometabolic health, particularly for emerging adult women. The primary purpose of this study is to test the preliminary efficacy of the intensive lifestyle intervention for EA women in reducing adiposity, as well as improving biomarkers of inflammation and metabolic risk over 12 months compared with a traditional behavioral weight loss intervention. This treatment program will be tested in emerging adult (EA) women ages 18-25 years old with a BMI of 25-50 kg/m\^2.
Basic eligibility
Full registry criteria
Treatments and study arms
Integrated Lifestyle Intervention (ILI)
ILI participants will receive training in empirically supported strategies to improve psychological function (e.g., restructuring negative thoughts, distress tolerance), with a focus on changing discrete behaviors linked to inflammation (e.g., sleep, processed foods, physical activity), all intertwined with BWL content adapted to meet the needs of EAs.
Monitoring with digital tools
All participants will receive digital tools to facilitate self-monitoring-the initial 4-month program will consist of group sessions via Zoom (8 weekly, 4 bi-weekly) with weekly tailored e-coaching, followed by monthly boosters through 12 months.
Primary outcomes
Change in adiposity (weight) between the two treatment arms across 12-months
Change in adiposity (waist circumference) between the two treatment arms across 12-months
Change in adiposity (% body fat) between the two treatment arms across 12-months
Study locations
1 locations were listed when this page was built. The first 40 are shown.